Accel Wealth Management’s Recursion Pharmaceuticals RXRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $224K | Buy |
44,200
+150
| +0.3% | +$759 | 0.07% | 232 |
|
|
2025
Q1 | $233K | Sell |
44,050
-1,750
| -4% | -$9.26K | 0.08% | 216 |
|
|
2024
Q4 | $310K | Buy |
+45,800
| New | +$310K | 0.12% | 183 |
|
|
2023
Q3 | – | Sell |
-10,330
| Closed | -$77.2K | – | 179 |
|
|
2023
Q2 | $77.2K | Buy |
10,330
+4,230
| +69% | +$31.6K | 0.04% | 167 |
|
|
2023
Q1 | $40.7K | Buy |
+6,100
| New | +$40.7K | 0.02% | 522 |
|